References
- 1. Vlahović-Palcevski V, Morović M, Palcevski G, Betica-Radić L. Antimicrobial utilization and bacterial resistance at three different hospitals. Eur J Epidemiol. 2001; 17(4): 375-83.
- 2. Willemsen I, Groenhuijzen A, Bogaers D, Stuurman A, van Keulen P, Kluytmans J. Appropriateness of antimicrobial therapy measured by repeated prevalence surveys. Antimicrob Agents Chemother. 2007; 51(3): 864-7.
- 3. Raymond DP, Pelletier SJ, Sawyer RG. Antibiotic utilization strategies to limit antimicrobial resistance. Semin Respir Crit Care Med 2002; 23(5): 497–501.
- 4. Urbánek K, Kolár M, Strojil J, Koukalová D, Cekanová L, Hejnar P. Utilization of fluoroquinolones and Escherichia coli resistance in urinary tract infection: inpatients and outpatients. Pharmacoepidemiol Drug Saf. 2005; 14(10): 741-5.
- 5. Johansen TE, Cek M, Naber KG, Stratchounski L, Svendsen MV, Tenke P; PEP and PEAP-study investigators; Board of the European Society of Infections in Urology. Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibiotics. Data from the PEP and PEAP-studies. Int J Antimicrob Agents. 2006; 28: S91-107.
- 6. Tandogdu Z, Cek M, Wagenlehner F, Naber K, Tenke P, van Ostrum E, Bjerklund, Johansen T. Resistance patterns of nosocomial urinary tract infections in urology departments: 8-year results of the global prevalence of infections in urology study. World J Urol. 2013. Epub ahead of print
- 7. Medina-Polo J, Jiménez-Alcaide E, García-González L, Guerrero-Ramos F, Pérez-Cadavid S, Arrébola-Pajares A, Sopeña-Sutil R, Benítez-Salas R, Díaz-González R, Tejido-Sánchez A. Healthcare-associated infections in a department of urology: Incidence and patterns of antibiotic resistance. Scand J Urol. 2013. Epub ahead of print
- 8. World Health Organization Collaborating Centre for Drug Statistics Methodology. About the ATC/DDD system. (Available at: http://www.whocc.no/filearchive/publications/1_2013guidelines.pdf Accessed 1.12. 2013).
- 9. Pešić G, Jović Z, Vasić K. Primena ATC/DDD metodologije pri upoređivanju upotrebe antibiotika u toku dvomesečnog perioda u dvema hirurškim bolnicama. Acta Facultatis Medicae Naissensis. 2006; 23(1): 39-44.
- 10. Radonjić V, Đukić L, Stefanović D, Tešić D. Promet i potrošnja antibiotika u Republici Srbiji. Arhiv za farmaciju. 2007; 57(4-5): 332-46.
- 11. Bulajić S, Hadžistević S, Milovanović D, Trajković G, Vujačić N, Stanojević Z. Upotreba antibiotika za sistemsku primenu u hirurškoj klinici KBC-Priština u Gračanici. Praxis medica. 2011; 39(1-2): 17-22.
- 12. Veliĉković-Radovanović R, Petrović J, Kocić B, Antić S, Randelović G. Correlation between antibiotic consumption and bacterial resistance as quality indicator of proper use of these drugs in inpatients. Vojnosanit Pregl. 2009; 66(4): 307-12.
- 13. Pavlović R, Janković S, Đorđević Z. Profile of urinary tract infections pathogens and their antimicrobial resistance patterns during three-year period (2009-2011) in the Clinical center Kragujevac. Racionalna terapija 2013; 5(2): 27-41.
- 14. Ghadiri H, Vaez H, Khosravi S, Soleymani E. The antibiotic resistance profiles of bacterial strains isolated from patients with hospital-acquired bloodstream and urinary tract infections. Crit Care Res Pract. 2012; 2012: 890797.
- 15. Van der Donk CF, Beisser PS, Hoogkamp-Korstanje JA, Bruggeman CA, Stobberingh EE; Antibiotic Resistance Surveillance Group. A 12 year (1998-2009) antibiotic resistance surveillance of Klebsiella pneumoniae collected from intensive care and urology patients in 14 Dutch hospitals. J Antimicrob Chemother. 2011; 66(4): 855-8.
- 16. Zilberberg MD, Chen J, Mody SH, Ramsey AM, Shorr AF. Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review. BMC Pulm Med 2010; 10: 45.
- 17. Lautenbach E, Synnestvedt M, Weiner MG, Bilker WB, Vo L, Schein J, Kim M. Imipenem resistance in Pseudomonas aeruginosa: emergence, epidemiology, and impact on clinical and economic outcomes. Infect Control Hosp Epidemiol. 2010; 31(1): 47-53.
- 18. Master RN, Clark RB, Karlowsky JA, Ramirez J, Bordon JM. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009. Int J Antimicrob Agents. 2011; 38(4): 291-5.
- 19. Jankovic S. Rational Use Of Antibiotics In Clinical Practice. Racionalna terapija 2009; 1(1): 1-6.